The EMIR REFIT will result in an expansion of the scope of AIFs that are considered to be a “financial counterparty” for the purposes of EMIR. ISDA have prepared an explanatory note to provide a high-level, factual overview of the effect of these changes, including the extent to which these changes might impact upon non-EU based alternative investment funds.
The note is available in English, Japanese and Korean.
Update: The note was updated on 7th June 2019 to take account of publication of the EMIR REFIT Regulation in the Official Journal of the European Union on 28th May 2019.
Documents (3) for ISDA Explanatory Note on Application of EMIR REFIT to Alternative Investment Funds (AIFs)
- ISDA EMIR REFIT Explanatory Note AIFS - updated 7th June 2019(pdf) will open in a new tab or window
- ISDA EMIR REFIT Explanatory Note AIFS (Japanese translation) - Updated 7 June 2019(pdf) will open in a new tab or window
- ISDA EMIR REFIT Explanatory Note AIFs (Korean translation)(pdf) will open in a new tab or window
Latest
ISDA Digital Assets Forum Opening Remarks
ISDA Digital Assets Forum Washington, DC October 6, 2026 Opening Remarks Scott O’Malia, CEO, ISDA Good morning, and a very warm welcome to the ISDA Digital Assets Forum. Thanks for joining us today, and a special thank you to...
Assessing Tokenized MMFs as Eligible Collateral
Distributed ledger technology and digital assets have matured from their early stages to solutions capable of addressing longstanding inefficiencies in collateral management. Tokenized money market funds (TMMFs) represent a particularly promising area for the application of this technology, combining the...
Response to EC on Carbon Accounting
On October 5, ISDA responded to the Joint Research Centre (JRC) of the European Commission (EC) survey, drawing on input from five member firms across the banking, exchange and market-data sectors. The response highlighted broad support for internationally recognized carbon...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
